Asia is a highly fragmented market, developing local healthcare & biotechnology solutions to service its large patient population. Startups, investors & corporates find it difficult to stay informed about the latest healthcare technologies. Sparkbio is building the first cross-border due-diligence platform with a centered focus on helping healthcare & biotech companies find capital and customers fast & ensure resources go to the best projects.